Lipella Pharmaceuticals INC
At a glance
Employees1-19
In business sinceNot reported
HeadquartersPittsburgh, PA
US patents4
SAM.gov UEIJBVNWFNEEV59
CAGE code480R9
Incorporated inPA
- therapies
- liposomal drug delivery technology
- clinical trials
- Phase 2 studies
- authorizations
- Food
- Drug Administration
- initial public
Named on the company’s own website, read JUL 29, 2026
Patents
4 US patents granted 2020–2025, 3 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Systems and methods of detecting interstitial cystitisUS 12,326,492 · granted JUN 10, 2025
- Delivery of agents using metastable liposomesUS 12,138,345 · granted NOV 12, 2024
- Delivery of agents using metastable liposomesUS 11,357,725 · granted JUN 14, 2022
- Delivery of agents using metastable liposomesUS 10,639,278 · granted MAY 5, 2020
Granted to Lipella Pharmaceuticals, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Lipella Pharmaceuticals INC | Pittsburgh | PA | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.